Alnylam Pharmaceuticals, Inc. (ALNY)

NASDAQ: ALNY · Real-Time Price · USD

216.12

-12.60 (-5.51%)

At close: Aug 6, 2026, 4:00 PM EDT

218.00

+1.88 (0.87%)

After-hours: Aug 6, 2026, 7:59 PM EDT

Alnylam Pharmaceuticals Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	1,708	1,657	966.43	812.69	866.39	819.98
Short-Term Investments	1,600	1,251	1,728	1,627	1,326	1,616
Cash & Short-Term Investments	3,308	2,908	2,695	2,439	2,192	2,436
Cash Growth	15.77%	7.94%	10.46%	11.27%	-9.98%	29.94%
Accounts Receivable	912.74	777.57	405.31	327.79	237.96	198.57
Inventory	97.11	82.72	78.51	89.15	128.96	86.36
Other Current Assets	302.18	281.89	116.96	126.38	132.92	88.08
Total Current Assets	4,620	4,051	3,295	2,983	2,692	2,809
Net Property, Plant & Equipment	737.5	708.06	693.93	725.79	738.63	733.63
Other Long-Term Assets	201.1	207.61	250.77	121.39	115.48	101.1
Total Assets	5,559	4,966	4,240	3,830	3,546	3,643
Accounts Payable	108.02	115.72	88.42	55.52	98.09	73.43
Accrued Expenses	1,096	1,080	793.69	713.01	545.46	395.17
Current Portion of Leases	45.93	45.52	41.89	41.51	41.97	40.55
Unearned Revenue	4.01	4.85	55.48	102.75	42.11	149.48
Other Current Liabilities	258.57	220.07	206.8	54.99	40.29	37.08
Total Current Liabilities	1,513	1,466	1,186	967.79	767.92	695.71
Long-Term Debt	1,011	1,008	1,025	1,021	1,017	675.7
Long-Term Leases	210.5	225.09	229.54	243.1	261.34	281.35
Other Long-Term Liabilities	1,471	1,478	1,732	1,819	1,658	1,402
Total Long-Term Liabilities	2,692	2,711	2,987	3,083	2,937	2,359
Total Liabilities	4,205	4,177	4,173	4,051	3,705	3,055
Common Stock	1.34	1.32	1.29	1.26	1.24	1.2
Additional Paid-in Capital	7,717	7,510	7,388	6,811	6,455	6,058
Accumulated Other Comprehensive Income	-32.14	-20.1	-34.52	-23.38	-44.65	-33.26
Retained Earnings	-6,332	-6,703	-7,288	-7,010	-6,569	-5,438
Shareholders' Equity	1,354	789.18	67.09	-220.64	-158.22	588.2
Total Liabilities & Equity	5,559	4,966	4,240	3,830	3,546	3,643
Total Debt	1,267	1,278	1,296	1,305	1,320	997.59
Net Cash (Debt)	2,041	1,630	1,398	1,134	872.16	1,438
Net Cash Growth	30.77%	16.56%	23.32%	30.02%	-39.35%	6.26%
Net Cash Per Share	14.84	12.10	10.96	9.08	7.17	12.14
Book Value	1,354	789.18	67.09	-220.64	-158.22	588.2
Book Value Per Share	9.85	5.86	0.53	-1.77	-1.30	4.97
Tangible Book Value	1,354	789.18	67.09	-220.64	-158.22	588.2
Tangible Book Value Per Share	9.85	5.86	0.53	-1.77	-1.30	4.97

SEC Filings: 10-K · 10-Q